Gossamer Bio, Inc. (GOSS)
0.1701
0.00 (0.00%)
USD |
NASDAQ |
Aug 27, 16:00
0.1707
0.00 (0.00%)
After-Hours: 19:05
Gossamer Bio Market Cap : 83.15M for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 85.01M |
| August 25, 2026 | 99.97M |
| August 24, 2026 | 85.55M |
| August 21, 2026 | 75.62M |
| August 20, 2026 | 76.99M |
| August 19, 2026 | 76.55M |
| August 18, 2026 | 69.95M |
| August 17, 2026 | 68.44M |
| August 14, 2026 | 75.38M |
| August 13, 2026 | 83.25M |
| August 12, 2026 | 86.82M |
| August 11, 2026 | 88.87M |
| August 10, 2026 | 41.33M |
| August 07, 2026 | 41.78M |
| August 06, 2026 | 41.87M |
| August 05, 2026 | 41.71M |
| August 04, 2026 | 42.60M |
| August 03, 2026 | 40.74M |
| July 31, 2026 | 39.78M |
| July 30, 2026 | 41.85M |
| July 29, 2026 | 48.51M |
| July 28, 2026 | 48.14M |
| July 27, 2026 | 46.80M |
| July 24, 2026 | 31.92M |
| July 23, 2026 | 33.44M |
| Date | Value |
|---|---|
| July 22, 2026 | 33.94M |
| July 21, 2026 | 36.33M |
| July 20, 2026 | 33.09M |
| July 17, 2026 | 39.92M |
| July 16, 2026 | 40.02M |
| July 15, 2026 | 37.95M |
| July 14, 2026 | 32.88M |
| July 13, 2026 | 33.82M |
| July 10, 2026 | 39.83M |
| July 09, 2026 | 41.07M |
| July 08, 2026 | 39.66M |
| July 07, 2026 | 41.66M |
| July 06, 2026 | 45.74M |
| July 02, 2026 | 40.65M |
| July 01, 2026 | 39.36M |
| June 30, 2026 | 38.63M |
| June 29, 2026 | 38.49M |
| June 26, 2026 | 36.85M |
| June 25, 2026 | 38.77M |
| June 24, 2026 | 39.66M |
| June 23, 2026 | 40.23M |
| June 22, 2026 | 38.54M |
| June 18, 2026 | 39.43M |
| June 17, 2026 | 42.01M |
| June 16, 2026 | 39.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 22.53B |
| Arbutus Biopharma Corp. | 1.021B |
| Kura Oncology, Inc. | 1.172B |
| ACADIA Pharmaceuticals, Inc. | 5.117B |
| Alnylam Pharmaceuticals, Inc. | 31.62B |
Market Cap Related Metrics
| PS Ratio | 0.8121 |
| PEG Ratio | -0.0178 |
| Price | 0.1701 |
| Earnings Yield | -409.1% |
| PEGY Ratio | -0.0178 |